Furthermore, Piers et al. revealed that AD-associated TREM2 LOF variants, including p.R47H, are defective in lipid binding, which results in the inability of microglia to convert their metabolic state from oxidative phosphorylation to glycolysis [53]. This evidence concerns the gene TREM2 and Alzheimer disease.